Simplify Logo

Full-Time

Senior Director

Clinical Supply Chain

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

201-500 employees

Specializes in precision oncology therapies

Hardware
Biotechnology
Healthcare

Compensation Overview

$235k - $281kAnnually

+ Equity Awards

Expert

San Carlos, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • B.S. or M.S. in scientific fields with 15+ years of experience in clinical supply chain and logistics
  • 5+ years of experience building and/or managing a clinical supply chain team
  • Strong experience managing clinical supply activities for global phase 3, randomized, oncology clinical trials
  • Working knowledge of import and export laws and processes
  • Working knowledge of pharmaceutical drug product development and manufacturing
  • Solid organizational and time management skills
  • Effective, open, and transparent communication skills (verbal and written)
  • Capable of working on multiple projects/tasks and able to meet timelines
  • Team-oriented, progressive thinker who enjoys participating in an innovative and creative work environment
Responsibilities
  • Lead a team to plan and deliver on-time, compliant clinical supply per the clinical development plan
  • Collaborate with cross-functional teams to proactively identify and mitigate potential risks
  • Serve as the clinical supply lead for assigned program(s) and develop/manage the clinical supply plan
  • Lead and manage clinical supply and logistics activities
  • Author, review, and/or approve related clinical and technical documents
  • Lead vendor identification, selection, onboarding, and management
  • Serve as a subject matter expert and develop continuous improvement plans for clinical supply GMP, GDP, and business processes

### Welcome to Revolution Medicines, crafting the future of oncology with precision. Our focus is on advancing RAS(ON) inhibitors and RAS Companion inhibitors, marked by the remarkable journey of our lead product, RMC-4630, through its clinical phases. Supported by a team of passionate oncology experts, we are steadfast in our mission to develop treatments that precisely target oncogenic mutations, promising a brighter, healthier tomorrow for patients everywhere. ###

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

17%

1 year growth

46%

2 year growth

111%